NASDAQ:HCWB 15 May 2026 - 20 May 2026

HCW Biologics Inc. shares jumped over 100% late Wednesday, pushing the volatile micro-cap biotech stock higher again after new securities filings, an ongoing Nasdaq listing dispute and the latest quarterly results.

HCW Biologics Inc. shares jumped more than threefold Friday. The clinical-stage biotech posted a first-quarter profit, reversing a year-earlier loss, as results got a boost from a licensing payment from Beijing Trimmune Biotech. The gain came from licensing, not product revenue.

HCW Biologics Inc. posted a first-quarter profit, boosted by revenue from a China licensing agreement. That windfall offers the small Florida biotech a temporary boost as it awaits initial human trial results for its top autoimmune candidate.